GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Ltd
Company typePublic
BSE500660
NSEGLAXO
IndustryPharmaceuticals & healthcare
PredecessorLaboratories (I) Ltd
Founded13 November 1924 (1924-11-13) as H. J. Foster & Co. Limited[1]
Headquarters,
India
ProductsMedicines and vaccines
RevenueIncrease 3,309 crore (US$400 million) (FY 2021)[2]
Increase 358 crore (US$43 million) (FY 2021)[2]
Number of employees
3500[3]
ParentGSK
Websiteindia-pharma.gsk.com

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK.[4][5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others.[6]

  1. ^ "GlaxoSmithKline Pharmaceuticals Ltd". The Economic Times. Retrieved 3 May 2020.
  2. ^ a b "GlaxoSmithKline Pharmaceuticals Limited" (PDF). gsk.com. Retrieved 29 January 2022.
  3. ^ "GlaxoSmithKline Pharmaceuticals Limited - Company". Gsk-india.com. 30 June 2010. Retrieved 30 September 2010.
  4. ^ "GlaxoSmithKline Pharmaceuticals Limited, Business Wire India, Press Releases, Dr. A Ramachandran". Businesswireindia.com. Archived from the original on 27 October 2010. Retrieved 30 September 2010.
  5. ^ "GSK Pharma plans more investments to support growth". The Hindu Business Line. 28 April 2010. Retrieved 30 September 2010.
  6. ^ "GlaxoSmithKline: Glaxo baby grows up". Business Today. Retrieved 29 January 2022.